CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Cash flows from operating activities
Net loss	$ (2,459,571)	$ (6,024,480)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation expense	8,502	8,502
(Gain) loss on debt extinguishment	(2,434,661)	2,268,373
Decrease in fair value of derivative liabilities	(618)	(12,321)
Amortization of discount on notes payable	1,447,400	1,740,150
Accrued interest on patents purchased	123,233	0
Amortization of patents and acquired contracts	811,989	831,123
Net cost of patents sold	0	215,372
Stock-based compensation	393,456	596,901
Changes in operating assets and liabilities
Accounts receivable	4,966	205,524
Inventories	0	130,155
Prepaid expenses and other current assets, net	(24,140)	(119,008)
Deferred expenses	(34,877)	315,058
Deposits and other assets	0	(10,000)
Accounts payable	(384,683)	(62,805)
Accrued expenses and other current liabilities	405,555	365,091
Deferred revenue	300,000	596,429
Net cash provided by (used in) operating activities	(1,843,449)	1,044,064
Cash flows from financing activities
Proceeds from issuance of preferred stock, net of issuance costs	2,425,000	0
Proceeds from issuance of common stock, net of issuance costs	1,182,278	1,835,000
Proceeds from issuance of notes payable	0	1,126,900
Payments on Fortress notes payable	(1,640,016)	0
Proceeds from related party note payable	(50,000)	0
Net cash provided by financing activities	1,917,262	2,961,900
Net decrease in cash and cash equivalents	73,813	4,005,964
Cash and cash equivalents, beginning of period	554,556	1,443,349
Cash and cash equivalents, end of period	628,369	5,449,313
Supplemental disclosures of cash flow information
Cash paid for interest	426,249	481,838
Supplemental disclosures of non-cash investing and financing activities
Accrued guaranteed payments and deferred expenses related to purchased patents	0	881,501
Conversion of portion of short term note payable, related party, to purchase common stock	0	100,000
Fair value of common stock warrants	$ 1,481,978	$ 0